SECsense Logo

Minerva Neurosciences, Inc. 8-K Report: Key Updates for Investors on January 10, 2025

$NERV
Form 8-K
Filed on: 2025-01-13
Source
Minerva Neurosciences, Inc. 8-K Report: Key Updates for Investors on January 10, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Minerva Neurosciences, Inc.
  • CIK Number: 0001598646
  • Business Structure: Corporation (incorporated in Delaware)
  • IRS Employer Identification Number (EIN): 26-0784194
  • Address: 1500 District Avenue, Burlington, MA 01803
  • Contact Phone Number: (617) 600-7373
  1. Report Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: January 10, 2025
  • SEC File Number: 000-36517
  1. Stock Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001 per share
  • Trading Symbol: NERV (NASDAQ)
  1. Period of Reporting:
  • Reporting Date: January 10, 2025
  • This indicates that the report is for a specific date rather than a period.
  1. XBRL Context:
  • The report uses the XBRL (eXtensible Business Reporting Language) format, which is designed for the electronic communication of business and financial data.

Insights:

  • The company Minerva Neurosciences, Inc. is actively reporting to the SEC, which is typical for public companies, indicating compliance with regulatory requirements.
  • The filing type (8-K) signifies that this report is likely disclosing significant events or changes that could affect the company's financial position or operations.
  • The mention of common stock with a very low par value suggests it may be a newer or smaller company, as par values can indicate the company’s capital structure.
  • The contact details and corporate structure imply transparency and accessibility for investors and stakeholders.

This information is critical for stakeholders assessing the company's current status and any significant developments that may arise from the filed 8-K.